ATE165367T1 - Cholesterinsenkende verbindungen und verfahren zu ihrer herstellung - Google Patents
Cholesterinsenkende verbindungen und verfahren zu ihrer herstellungInfo
- Publication number
- ATE165367T1 ATE165367T1 AT92921189T AT92921189T ATE165367T1 AT E165367 T1 ATE165367 T1 AT E165367T1 AT 92921189 T AT92921189 T AT 92921189T AT 92921189 T AT92921189 T AT 92921189T AT E165367 T1 ATE165367 T1 AT E165367T1
- Authority
- AT
- Austria
- Prior art keywords
- hydroxymethylhexose
- sterol
- cholesterol
- production
- hexaacylated
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229930182558 Sterol Natural products 0.000 abstract 3
- 150000003432 sterols Chemical class 0.000 abstract 3
- 235000003702 sterols Nutrition 0.000 abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229930182490 saponin Natural products 0.000 abstract 1
- 150000007949 saponins Chemical class 0.000 abstract 1
- 235000017709 saponins Nutrition 0.000 abstract 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003648 triterpenes Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J17/005—Glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77166891A | 1991-10-04 | 1991-10-04 | |
| US77170991A | 1991-10-04 | 1991-10-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE165367T1 true ATE165367T1 (de) | 1998-05-15 |
Family
ID=27118506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92921189T ATE165367T1 (de) | 1991-10-04 | 1992-09-29 | Cholesterinsenkende verbindungen und verfahren zu ihrer herstellung |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0607245B1 (de) |
| JP (1) | JPH06511250A (de) |
| AT (1) | ATE165367T1 (de) |
| AU (1) | AU2753292A (de) |
| DE (1) | DE69225233T2 (de) |
| ES (1) | ES2114948T3 (de) |
| GR (1) | GR3026698T3 (de) |
| PT (1) | PT100922B (de) |
| WO (1) | WO1993007167A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07504921A (ja) * | 1992-06-26 | 1995-06-01 | フアイザー・インコーポレイテツド | 高コレステロール血症を治療するためのステロイドグリコシド |
| US5760009A (en) * | 1993-04-28 | 1998-06-02 | Pfizer Inc. | Spirostanyl glycosidal crystalline monohydrate |
| US5502038A (en) * | 1993-06-21 | 1996-03-26 | Medical Research Foundation Of Oregon | Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption |
| ES2074006B1 (es) * | 1993-07-05 | 1996-03-16 | Pfizer | Glicosidos esteroidales para tratar hipercolesterolemia. |
| US6150336A (en) * | 1995-05-29 | 2000-11-21 | Pfizer Inc. | Steroidal glycosides |
| US5756470A (en) * | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| CA2389670A1 (en) * | 1999-11-01 | 2001-05-10 | Forbes Medi-Tech Inc. | Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| ATE331512T1 (de) | 2001-01-26 | 2006-07-15 | Schering Corp | Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie |
| HU230253B1 (hu) | 2001-01-26 | 2015-11-30 | Merck Sharp & Dohme Corp | Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| FI20010780A0 (fi) | 2001-04-12 | 2001-04-12 | Raisio Benecol Oy | Parannetut koostumukset |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| EP1429756B1 (de) | 2001-09-21 | 2006-11-22 | Schering Corporation | Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption |
| JP2006508189A (ja) | 2002-11-06 | 2006-03-09 | シェーリング コーポレイション | 自己免疫障害の処置のためのコレステロール吸収インヒビター |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| JP4589919B2 (ja) | 2003-03-07 | 2010-12-01 | シェーリング コーポレイション | 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用 |
| US7192944B2 (en) | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| DE602004016123D1 (de) | 2003-03-07 | 2008-10-09 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
| ES2527179T3 (es) | 2009-11-02 | 2015-01-21 | Pfizer Inc. | Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol |
| RU2696490C2 (ru) | 2014-05-19 | 2019-08-02 | Пфайзер Инк. | Замещенные-6,8-диоксабицикло[3.2.1.]октан-2,3-диольные соединения в качестве агентов, нацеленных на ASGPR |
| JP6869894B2 (ja) | 2015-03-20 | 2021-05-12 | オーフス ウニベルシテット | リポタンパク質代謝障害の治療のためのｐｃｓｋ９阻害剤 |
| JP7046381B2 (ja) | 2016-09-20 | 2022-04-04 | オーフス ウニベルシテット | リポタンパク質代謝障害の治療のための化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4602005A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis |
| US5041541A (en) * | 1988-05-05 | 1991-08-20 | The Procter & Gamble Company | Functional sugar substituted with reduced calories |
-
1992
- 1992-09-29 AT AT92921189T patent/ATE165367T1/de not_active IP Right Cessation
- 1992-09-29 EP EP92921189A patent/EP0607245B1/de not_active Expired - Lifetime
- 1992-09-29 DE DE69225233T patent/DE69225233T2/de not_active Expired - Fee Related
- 1992-09-29 AU AU27532/92A patent/AU2753292A/en not_active Abandoned
- 1992-09-29 ES ES92921189T patent/ES2114948T3/es not_active Expired - Lifetime
- 1992-09-29 WO PCT/US1992/008290 patent/WO1993007167A1/en not_active Ceased
- 1992-09-29 JP JP50700993A patent/JPH06511250A/ja active Pending
- 1992-10-01 PT PT100922A patent/PT100922B/pt not_active IP Right Cessation
-
1998
- 1998-04-23 GR GR980400751T patent/GR3026698T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06511250A (ja) | 1994-12-15 |
| WO1993007167A1 (en) | 1993-04-15 |
| EP0607245B1 (de) | 1998-04-22 |
| ES2114948T3 (es) | 1998-06-16 |
| GR3026698T3 (en) | 1998-07-31 |
| DE69225233D1 (de) | 1998-05-28 |
| EP0607245A1 (de) | 1994-07-27 |
| PT100922A (pt) | 1993-10-29 |
| DE69225233T2 (de) | 1998-11-19 |
| PT100922B (pt) | 1999-08-31 |
| AU2753292A (en) | 1993-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE165367T1 (de) | Cholesterinsenkende verbindungen und verfahren zu ihrer herstellung | |
| Dowling et al. | Effects of controlled interruption of the enterohepatic circulation of bile salts by biliary diversion and by ileal resection on bile salt secretion, synthesis, and pool size in the rhesus monkey | |
| FR2550092B1 (fr) | Preparation medicamenteuse solide a deux phases et son procede d'obtention | |
| PT73879A (de) | 1-carboxyalkanoylindolin-2-carbonsauren verfahren zu ihrer herstellung und pharmazeutische praeparate enthaltend diese verbindungen sowie ihre therapeutische verwendung | |
| Hofmann et al. | Chenotherapy for gallstone dissolution: II. Induced changes in bile composition and gallstone response | |
| DE2964868D1 (en) | Dibenz(b,f)(1,4)oxazepine derivatives, process for their preparation and pharmaceutical compositions | |
| DE3682811D1 (de) | Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung. | |
| ATE6645T1 (de) | Dibenzoxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| JPS5745199A (en) | Esterification product and cosmetic or external use preparation containing the same | |
| PT75217B (de) | Magenvertragliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung | |
| ATE121396T1 (de) | Dibenzo(1,5)dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung. | |
| ATE1066T1 (de) | Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahy dro-1h-1-benzazepin-2-ons, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| JPS55122718A (en) | Preparation of health drink | |
| ATE11528T1 (de) | Salze der cholsaeuren, verfahren zu ihrer herstellung und therapeutische zusammensetzungen, die sie als aktiven bestandteil enthalten. | |
| JPS5735599A (en) | 24,25-dihydroxycholestane and its preparation | |
| JPS55161801A (en) | Fluorescence-labeled acid mucopolysaccharide and preparation thereof | |
| JPS5545648A (en) | 2-formyldibenzazepin derivative and its preparation | |
| JPS5927824A (ja) | 抗脂血剤 | |
| JPS55154940A (en) | 2,3-butanediol ester, its preparation and use | |
| JPS5677237A (en) | 2-substituted-hydroxycyclopentenone and its preparation | |
| JPS5590504A (en) | Preparation of unsoluble chitin derivative | |
| JPS5780370A (en) | Alpha-methylcinnamic acid derivative, its preparation and antilipemic agent containing the same | |
| JPS57106691A (en) | Novel glyceroglycolipid compound and its preparation | |
| JPS5671085A (en) | Production of 2-hydroxy-5-alkyl-tetrahydrofuran and its novel intermediate | |
| Portoghese | Prostaglandins: the once-a-month birth control pill of the future |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |